We are live on ! Find out more
MCM

Maryland Capital Management Portfolio holdings

AUM $1.2B
1-Year Est. Return 18.21%
This Fund
S&P 500
This Quarter Est. Return
-12.46%
1 Year Est. Return
-18.21%
3 Year Est. Return
+44.51%
5 Year Est. Return
+97.8%
10 Year Est. Return
AUM
$692M
AUM Growth
-$72.8M
Cap. Flow
+$28.5M
Cap. Flow %
4.12%
Top 10 Hldgs %
35.07%
Holding
186
New
18
Increased
81
Reduced
41
Closed
13

Sector Composition

Rank Sector Weight
1 Technology 17.12%
2 Healthcare 15.89%
3 Financials 15.01%
4 Consumer Discretionary 14.88%
5 Communication Services 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
26
Meta Platforms (Facebook)
META
$1.51T
$9.4M 1.36%
71,678
-618
-0.9% -$89.5K
VMC icon
27
Vulcan Materials
VMC
$36.9B
$9.28M 1.34%
93,878
-11,206
-11% -$1.14M
CXO
28
DELISTED
CONCHO RESOURCES INC.
CXO
$8.8M 1.27%
85,606
+195
+0.2% +$25.9K
VB icon
29
Vanguard Morningstar Small-Cap ETF
VB
$82.7B
$8.23M 1.19%
62,361
+1,690
+3% +$246K
VNQ icon
30
Vanguard Real Estate ETF
VNQ
$39.1B
$8.19M 1.18%
109,763
+2,657
+2% +$209K
T icon
31
AT&T
T
$163B
$6.65M 0.96%
308,325
+6,837
+2% +$159K
DUK icon
32
Duke Energy
DUK
$97.3B
$6.42M 0.93%
74,367
+1,468
+2% +$125K
VO icon
33
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$6.05M 0.87%
175,256
+3,096
+2% +$116K
XOM icon
34
ExxonMobil
XOM
$634B
$5.98M 0.86%
87,653
+1,881
+2% +$148K
VWO icon
35
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$5.89M 0.85%
154,697
+28,688
+23% +$1.11M
INTC icon
36
Intel
INTC
$513B
$5.59M 0.81%
119,218
+3,086
+3% +$144K
PFE icon
37
Pfizer
PFE
$153B
$5.14M 0.74%
124,079
+8,605
+7% +$357K
PG icon
38
Procter & Gamble
PG
$339B
$5.11M 0.74%
55,635
+1,035
+2% +$92.5K
VEA icon
39
Vanguard FTSE Developed Markets ETF
VEA
$237B
$5.07M 0.73%
136,678
+2,265
+2% +$89.7K
CVX icon
40
Chevron
CVX
$366B
$4.77M 0.69%
43,808
+2,247
+5% +$260K
ABBV icon
41
AbbVie
ABBV
$435B
$4.76M 0.69%
51,616
+1,987
+4% +$175K
MCD icon
42
McDonald's
MCD
$195B
$4.44M 0.64%
25,011
+1,408
+6% +$250K
SO icon
43
Southern Company
SO
$107B
$4.17M 0.6%
94,873
+10,185
+12% +$463K
IVV icon
44
iShares Core S&P 500 ETF
IVV
$904B
$4.08M 0.59%
16,206
-1,702
-10% -$462K
JNJ icon
45
Johnson & Johnson
JNJ
$625B
$4.05M 0.58%
31,360
+2,388
+8% +$333K
LLY icon
46
Eli Lilly
LLY
$1.06T
$4.04M 0.58%
34,955
+2,335
+7% +$261K
JPM icon
47
JPMorgan Chase
JPM
$950B
$3.86M 0.56%
39,555
+4,174
+12% +$445K
DD icon
48
DuPont de Nemours
DD
$19.2B
$3.8M 0.55%
28,057
+1,202
+4% +$173K
SDIV icon
49
Global X SuperDividend ETF
SDIV
$1.22B
$3.68M 0.53%
71,689
-4,811
-6% -$272K
MRK icon
50
Merck
MRK
$318B
$3.65M 0.53%
50,005
+2,467
+5% +$174K

Similar funds

Maryland Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Maryland Capital Management held 186 positions worth $692M, down 9.5% from $765M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Maryland Capital Management deployed $28.5M of net new capital in Q4 2018, opening 18 new positions and adding to 81 existing holdings. Its largest new stake was Edwards Lifesciences: 47,016 shares worth $2.4M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Pultegroup, an estimated $15.9M trimmed.

  • Maryland Capital Management's largest Q4 2018 buy was Edwards Lifesciences: 47,016 shares worth $2.4M.
  • Maryland Capital Management added most to VF Corp in Q4 2018, an estimated $15.6M increase.
  • Maryland Capital Management's biggest Q4 2018 reduction was Pultegroup, cutting an estimated $15.9M.
  • Maryland Capital Management fully exited Goldman Sachs in Q4 2018, selling an estimated $12M.
  • Maryland Capital Management's ten largest holdings make up 35% of its $692M portfolio in Q4 2018.
  • Maryland Capital Management opened 18 new positions and closed 13 in Q4 2018.
  • Maryland Capital Management's portfolio value fell 9.5% quarter-over-quarter to $692M.

Based on Maryland Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.